NCT03464097
Who may be able to join
Who might be able to join this trial:
- You met the requirements to join the earlier part of this study (called the "induction study") and completed all required assessments at the 12-week mark.
- At week 12 of the induction study, you were showing improvement or were in remission, meaning your symptoms — such as number of bowel movements per day and abdominal pain — were well-controlled and no worse than when you started.
Who may not be able to join:
- You have had surgery to remove part or all of your large bowel, part of your small bowel, or have had a stoma (an opening created in the abdomen for waste) since the start of the induction study, or you have developed a new fistula (an abnormal tunnel connecting organs).
- You have recently received certain treatments, including steroid suppositories or enemas, rectal anti-inflammatory medicines (called 5-aminosalicylates), steroid injections or infusions, immune-suppressing drugs, experimental treatments, or a blood-filtering treatment called apheresis (confirm with trial site for exact timing details).
Important: Always verify eligibility with the trial site directly before applying.
For more information about this Bristol-Myers Squibb study, you can also visit: www.BMSStudyConnect.com
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
26 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage of Participants Who Achieve Crohn's Disease Activity Index (CDAI) Score < 150 at Week 52 as Observed; Percentage of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline ≥ 50% Based on Observed Cases and Robarts Observed Scores
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.